# Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/aliskiren-a-novel-orally-effective-renin-inhibitor-provides-dose-dependent/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alan H. Gradman,Roland E. Schmieder,R. Lins,Juerg Nussberger,YannTong Chiang,Martin P. Bedigian |
| Citations | 524 |
| DOI | 10.1161/01.cir.0000156466.02908.ed |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2015569360 |
| PMID | 15723979 |
| Type | article |
| Year | 2005 |

## Paper authors

- [R. Lins](https://scholariq.org/researchers/r-lins/)
- [Roland E. Schmieder](https://scholariq.org/researchers/roland-e-schmieder/)

## Paper journal

- [Circulation](https://scholariq.org/journals/circulation/)

## Paper primary topic

- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)

## Paper topics

- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.